Erasca, Inc. SEC filings ERAS

Erasca, Inc. has 352 filings in SEC EDGAR's recent list, going back to Jan 15, 2019. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
S-8 Employee stock plan registration Aug 11, 2026 —
424B5 Prospectus supplement Jul 14, 2026 —
424B5 Prospectus supplement Jul 13, 2026 —
S-3ASR Automatic shelf registration Jul 13, 2026 —
424B5 Prospectus supplement Jan 22, 2026 —
424B5 Prospectus supplement Jan 20, 2026 —
S-3 Shelf registration Aug 12, 2025 —
424B5 Prospectus supplement May 17, 2024 —
S-3 Shelf registration May 9, 2024 —
S-8 Employee stock plan registration May 9, 2024 —
424B5 Prospectus supplement Dec 9, 2022 —
S-3 Shelf registration Aug 11, 2022 —
S-8 Employee stock plan registration Jul 16, 2021 —
424B4 Prospectus Jul 16, 2021 —
S-1MEF Filing Jul 15, 2021 —
S-1/A Amended registration statement Jul 12, 2021 —
S-1 Registration statement Jun 25, 2021 —

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ERAS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
, Emerging growth company
SEC CIK
1761918

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.